THE PEER-REVIEWED STAKEHOLDERS’ FORUM FOR DRUG BENEFIT DESIGN™ FEBRUARY 2008
VOLUME 1, NUMBER 1
REGULATORY
Creating a 21st-Century Intelligent Health System Newt Gingrich, Nancy Desmond
Interview: The Impact of CMS on Biotech Drug Coverage (Part 1) Joseph Antos BUSINESS
Disruptive Innovation: Value-Based Health Plans ™
F. Randy Vogenberg
Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate Al B. Benson, Elizabeth Brown CLINICAL
Measuring the Value of Treatment to Patients: Patient-Reported Outcomes in Drug Development Richard J. Willke EDITORIAL
What Kind of Healthcare Debate Do We Want? Robert E. Henry COLUMNS
- FDA Watch - Industry Trends
©2008 Engage Healthcare Communications, LLC www.AHDBonline.com
R E I M E E U PR ISS